demonstrated that NT-I7 mitigated RT-related lymphopenia, increased cytotoxic CD8+ T lymphocyte numbers throughout the body and in the tumor, and prolonged the survival of orthotopic glioma-bearing mice (111). The gene discussed is CD8A; the disease is neoplasm.